What is a filler granuloma? Differences from filler clumping, symptoms, and treatment
[Medical advertising notice]
Diagnosis and treatment may vary with the filler type, injection site, and cause of symptoms, so a specific treatment plan must be determined through medical examination.
When an injected area becomes firm or lumpy over time, people often describe it as 'filler clumping'.
However, not every lump after filler treatment is simply clumped filler.
Nodules may have various causes, including excessive filler in one spot, filler migration, infection, fibrosis, delayed inflammatory reactions, and granulomatous reactions to foreign material.
Rather than judging a filler granuloma by appearance or touch alone, treatment history, symptoms, and, when needed, imaging or biopsy findings must be considered together.
What is a filler granuloma?
A filler granuloma is a chronic inflammatory lesion formed by accumulated inflammatory cells, including macrophages and multinucleated giant cells, during a persistent foreign-body reaction to injected material.
It differs from simple 'clumping', in which filler physically collects in one place.
Although all late-onset firm nodules after filler treatment are sometimes called granulomas, medically it is necessary to distinguish 'delayed inflammatory nodules' from 'foreign-body granulomas'.
A delayed inflammatory nodule is a clinical description of swelling or a firm lump appearing some time after treatment; a foreign-body granuloma is one possible cause of such nodules.
A biopsy is needed for histological confirmation of a granulomatous reaction, but not every patient undergoes biopsy.
A filler granuloma is an inflammatory nodule or mass formed through a chronic foreign-body reaction to filler material, rather than simple filler clumping.
The U.S. Food and Drug Administration (FDA) also advises that nodules or granulomas can occur relatively rarely within or beneath the skin after filler treatment, and some may require injections or surgery.
Why do filler granulomas develop?
Filler granulomas are unlikely to have a single cause. Material properties, injection location, individual tissue reactions, and possible infection may contribute together.
1. Foreign-body reaction to filler material
Filler is an external material injected into the body. Most remains without particular problems or breaks down over time, but in some cases a persistent foreign-body reaction may produce a chronic inflammatory lesion.
This reaction can rarely occur with hyaluronic acid fillers and is also reported with nonabsorbable or semipermanent injected materials.
When the injected substance is unknown or treatment was performed outside a medical facility, difficulty identifying the composition and extent of injection may complicate diagnosis and treatment.
2. Infection-related inflammatory reactions
Infection or biofilms have been proposed as possible contributors to some delayed inflammatory nodules after filler treatment.
However, not all delayed nodules are caused by infection, and biofilms may be difficult to confirm with routine testing.
Pain, redness, warmth, pus, or skin damage warrants priority assessment for infection.
Caution is needed because treatment that only suppresses inflammation without adequately assessing for infection may worsen the condition.
3. Filler composition and physical properties
Fillers vary in composition and mechanism, including hyaluronic acid, calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polymethyl methacrylate (PMMA).
Historically, substances such as silicone or paraffin, which differ from commonly used contemporary cosmetic fillers, have also been injected.
Tissue reactions and treatment may vary with particle size, surface properties, and whether the material can break down. Identifying the product or ingredient can therefore help diagnosis and treatment planning.
Overfilling and repeated treatments must be distinguished from granulomas
Large amounts or repeated injections in one area may leave filler irregularly distributed within tissue or palpable as nodules.
These may be noninflammatory nodules caused by overfilling or uneven distribution, rather than granulomas.
After repeated treatments, however, different fillers may remain in several tissue layers, and an unclear treatment history may complicate diagnosis and treatment.
Large amounts of residual filler or firmness alone should therefore not be interpreted as a granuloma.
Noninflammatory nodules from simple overfilling and inflammatory nodules require distinction because treatment may differ.
When do filler granulomas appear?
Filler granulomas do not necessarily appear immediately after treatment.
They may be found months or years later, and nonabsorbable or unidentified foreign material may cause symptoms long after injection.
Onset alone cannot diagnose a filler granuloma, however. Simple overfilling or migration may also be discovered late, and infectious nodules can develop at various times after treatment.
The following symptoms may occur.
- A firm lump at the injection site
- An uneven or asymmetric skin surface
- Sudden swelling in a previously unproblematic area
- Recurrent redness, tenderness, or warmth
- Nodules that enlarge or are palpable in several areas
- Skin discoloration or inflammation that subsides and then recurs
- Skin thinning, wounds, or discharge
These symptoms can occur with infection, abscesses, filler migration, overfilling, fibrosis, or other delayed inflammatory reactions as well as granulomas.
How does this differ from simple filler clumping?
Nodules at filler injection sites must be distinguished according to the cause of symptoms and presence of inflammation.
Category / Commonly observed features
Simple overfilling or uneven distribution / A localized protrusion or unevenness without pain, redness, or warmth
Filler migration / Volume or a lump in a location different from the original injection site
Delayed inflammatory nodule / Swelling, tenderness, redness, or firmness, possibly with recurrent symptoms
Infectious nodule or abscess / Pain, redness, warmth, or discharge, although chronic infection may have subtle symptoms
Foreign-body granuloma / Persistent firm nodules or recurrent inflammation; histological confirmation may be needed
These features alone cannot establish the cause. Assessment must consider not only onset and feel, but also pain, redness, warmth, injected material, and lesion location and extent.
How are filler granulomas diagnosed?
A detailed treatment history is an important first step in diagnosis.
- When treatment was performed
- Where the material was injected
- Which product and ingredients were used
- The volume injected and number of repeat treatments
- When symptoms first appeared
- Whether pain, warmth, swelling, or discharge is present
- Any previous filler dissolution or removal treatment
If the product name is forgotten or treatments were repeated at several clinics, identifying the filler composition and injection extent may be difficult.
When needed, ultrasound can assess the location and extent of material suspected to be filler or foreign material, nodule morphology, and fluid collections.
However, ultrasound findings alone cannot confirm a granuloma or infection.
If infection is suspected, cultures or other tests may be considered depending on the lesion.
Test results alone do not always clearly establish whether infection is present, so clinical symptoms and examination findings must also be considered.
A biopsy may be needed to confirm a granulomatous reaction histologically. However, not every nodule requires biopsy; the need is determined from treatment history, examination, imaging, and response to treatment.
How are filler granulomas treated?
Treatment varies with the filler composition, lesion location and extent, presence of infection, and surrounding tissue condition.
Automatically using dissolving injections or surgical removal just because an injection site feels firm may be inappropriate.
When hyaluronic acid filler remains
If hyaluronic acid filler is considered the cause, hyaluronidase may be used to attempt its breakdown.
However, hyaluronidase breaks down hyaluronic acid and is not effective for all fillers or foreign substances.
If fibrosis or granulomatous inflammation has already formed around the filler, reducing the hyaluronic acid may not completely resolve firmness or inflammation.
When an inflammatory granuloma is suspected
If examination and necessary testing indicate a low likelihood of infection, treatments to control inflammation, such as intralesional corticosteroid injections, may be considered.
Additional treatment may be needed depending on the lesion and treatment response.
Because these treatments can cause adverse effects such as skin atrophy, depressions, and pigment changes, they must be used carefully according to lesion location and skin thickness.
When infection is suspected
With findings such as pain, redness, warmth, or pus suggesting infection, necessary tests may be followed by antibiotics or drainage at the clinician's discretion.
Antibiotics are not needed for every nodule without confirmed infection; conversely, suppressing inflammation alone without adequately assessing possible infection also requires caution.
When surgical removal is needed
Surgical removal may be considered when nonabsorbable filler or unidentified injected material causes recurrent inflammation, skin damage occurs, or a firm mass does not respond to nonsurgical treatment.
However, nonabsorbable filler does not necessarily require surgical removal. Treatment must consider symptom severity, lesion extent, and the condition of skin and surrounding tissue together.
If filler or foreign material is widely dispersed among normal tissue or adherent to surrounding tissue, complete removal in one operation may be difficult.
Aggressive removal involving normal tissue can cause depressions, scars, asymmetry, nerve or vascular injury, and changes in facial expression, so the removable extent and surgical limitations must be considered.
What to avoid when a filler granuloma is suspected
Repeatedly doing the following before identifying the cause may worsen symptoms or hinder accurate diagnosis.
- Pressing firmly on a lump or repeatedly massaging it
- Repeated dissolving injections without checking the product composition
- Injections to suppress inflammation without assessing for infection
- Leaving pain, redness, or warmth unassessed for a prolonged period
- Further injections or removal procedures outside a medical facility
Keep any medical records or product information from previous treating clinics.
Records identifying the treatment date, site, and product can provide important information if an adverse reaction develops later.
Which symptoms need prompt medical evaluation?
Do not delay assessment if nodules enlarge or the following changes occur.
- Increasing pain, redness, or warmth
- Swelling that subsides and repeatedly returns
- Thinning or discolored skin
- Skin breakdown, pus, or discharge
- An expanding area of nodules
- Associated fever or systemic symptoms
Emergency symptoms immediately after filler injection
Severe pain during or immediately after injection, white, gray, or blue skin, blurred or reduced vision, or eye pain requires priority assessment for an emergency complication such as vascular occlusion rather than a granuloma.
If these symptoms occur, do not wait or massage the area on your own; immediately attend the treating clinic or a facility providing emergency care.
Frequently asked questions
Q. Is every firm filler lump a granuloma?
A. No. Firmness may result from overfilling, uneven distribution, migration, fibrosis, infection, or delayed inflammatory nodules. Touch alone cannot confirm a granuloma.
Q. Can hyaluronic acid filler cause granulomas?
A. Yes. Although hyaluronic acid filler breaks down in the body, delayed inflammatory reactions and foreign-body granulomas are rarely reported. However, not every delayed nodule after hyaluronic acid filler is a histological granuloma.
Q. Can dissolving injections eliminate a filler granuloma?
A. Hyaluronidase may help when hyaluronic acid filler remains. It is ineffective for non-hyaluronic acid fillers, and additional treatment may be needed when fibrosis or granulomatous inflammation has already developed.
Q. Can filler injected long ago cause problems?
A. Yes. Filler granulomas or delayed inflammatory reactions may appear months or years after treatment. Problems with unidentified or nonabsorbable substances in particular may be discovered long afterward.
Q. Do filler granulomas always require surgery?
A. No. Nonsurgical treatment may be considered first depending on composition, infection status, lesion size and extent, and skin condition.
However, recurrent inflammation, skin damage, or a mass unresponsive to treatment may warrant consideration of surgical removal.
Q. Can surgery remove all filler?
A. Whether removal is possible and how much can be removed depend on the material's type, location, and adhesions to surrounding tissue.
Even a relatively localized lesion may be difficult to remove completely if closely attached to normal tissue or important structures such as nerves and blood vessels.
The priority is therefore to assess how much of the symptomatic lesion can be safely removed while limiting normal tissue damage, rather than indiscriminately removing all filler.
For filler granulomas, identifying the precise cause comes first
A filler granuloma is an inflammatory lesion formed through a chronic foreign-body reaction to injected material, rather than simple filler clumping.
It may appear months or years later as firm nodules, recurrent swelling and redness, pain, or skin changes.
However, not every lump after filler treatment is a granuloma.
Simple overfilling, migration, fibrosis, infection, abscesses, and other delayed inflammatory reactions must be distinguished, and treatment may accordingly involve hyaluronidase, medication, drainage, or surgical removal.
Particularly when a remote treatment has left the filler composition unknown or repeated injections were performed in several areas, treatment planning should assess the skin and surrounding tissue as well as lesion location and extent.
If you are concerned about filler granulomas or clumping, contact 02-545-3700 or 'UVOM Plastic Surgery' on KakaoTalk.
For more columns on facial foreign-material removal, select a title below.
Why the difference with the same ingredient? Why PDO and PCL 'fillers' may cause granulomas when 'threads' are tolerated
How can an unidentified substance injected into the face long ago be assessed?
I have been told old filler still remains. Can it all be removed?
Why tissue around facial foreign material becomes hard
Can granulomas develop years after filler treatment?
References
1. U.S. Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers)
2. Urdiales-Gálvez F, et al. Treatment of Soft Tissue Filler Complications: Expert Consensus Recommendations. Aesthetic Plastic Surgery. 2018.
3. Lee JM, Kim YJ. Foreign Body Granulomas after the Use of Dermal Fillers: Pathophysiology, Clinical Appearance, Histologic Features, and Treatment. Archives of Plastic Surgery. 2015.